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Abstract—Quantification of metabolites from magnetic resonance spectra (MRS) has many applications in medicine and psychology,
but remains a challenging task despite considerable research efforts. For example, the neurotransmitter γ-aminobutyric acid (GABA),
present in very low concentration in vivo, regulates inhibitory neurotransmission in the brain and is involved in several processes
outside the brain. Reliable quantification is required to determine its role in various physiological and pathological conditions. We
present a novel approach to quantification of metabolites from MRS with convolutional neural networks — MRSNet. MRSNet is trained
to perform the multi-class regression problem of identifying relative metabolite concentrations from given input spectra, focusing
specifically on the quantification of GABA, which is particularly difficult to resolve. Typically it can only be detected at all using special
editing acquisition sequences such as MEGA-PRESS. A large range of network structures, data representations and automatic
processing methods are investigated. Results are benchmarked using experimental datasets from test objects of known composition
and compared to state-of-the-art quantification methods: LCModel, jMRUI (AQUES, QUEST), TARQUIN, VeSPA and Gannet. The
results show that the overall accuracy and precision of metabolite quantification is improved using convolutional neural networks.
Index Terms—Convolutional Neural Networks, Multi-class Regression, Magnetic Resonance Spectroscopy, Metabolite Quantification,
GABA, MEGA-PRESS.
F
1 INTRODUCTION
MAGNETIC resonance spectroscopy (MRS) is a rapidlydeveloping, highly versatile tool, enabling us to ac-
quire information about biochemical processes happening
in vivo and to identify biochemical changes associated with
various cancers and neurological disorders among others.
The technique is non-invasive, painless, involves no ioniz-
ing radiation or radioactive tracers and can be performed on
conventional clinical MRI scanners available in many hospi-
tals. MRS has been responsible for advances in detecting,
classifying and modelling malignant tissue in the brain [1],
[2], [3], prostate [4], [5], [6] and breast [7], [8], [9]. It also has a
role in modern psychology and neuroscience, where it pro-
vides a useful window into normal brain function, as well
as abnormalities associated with conditions such as anxiety,
schizophrenia, depression and other mood disorders [10],
[11], [12], [13], [14]. Many of these studies have focused on
the detection of γ-aminobutyric acid (GABA), the primary
inhibitory neurotransmitter [15], as a key biomarker. Its
quantification is especially difficult as it is present in low
concentration in vivo and its characteristic MRS features
overlap with those of much more abundant metabolites,
such as N-Acetylaspartic acid (NAA) and Creatine (Cr),
obscuring its signature in MR spectra. This had lead to
the development of new spectroscopic techniques, such as
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edited spectroscopy, that attempt to selectively edit out
certain features to make others observable. In this work, we
focus on quantification of GABA with MEGA-PRESS, one of
the most commonly used edited spectroscopy sequences.
An MR spectrum is a graph of the magnetic resonance
signal S(ν) as a function of frequency ν. MR spectra of
different molecules have different features such as a set
of characteristic peaks at distinct frequencies. While indi-
vidual MR spectra are highly molecule-specific, identifying
and quantifying the concentration of molecules from MR
spectra of mixtures containing many molecules is a very
challenging task as spectral features of different molecules
overlap, signals from molecules present in low concentra-
tion may be barely distinguishable from the noise floor,
resulting in low signal-to-noise ratios (SNR), and hardware
or software calibration issues may distort the spectra ob-
tained. In essence, quantification decomposes spectra into
features associated with individual metabolites to infer the
chemical composition of a sample or tissue voxel. There are
many ways to tackle quantification, such as basis set fitting,
singular value decomposition, principal component analysis
or peak integration, focusing on either time or frequency
domain analysis. In addition, spectral processing methods
are employed for phase correction, removal of water or
macro-molecule signals and baseline correction. Many of
these require manual calibration and spectral processing
may lead to distortion of spectra, thereby falling short of
achieving accurate and precise quantification with minimal
input from a human expert. [16] is an excellent review of the
state-of-the-art.
Basis set methods achieve decomposition by represent-
ing a spectrum as a linear combination of spectra from a
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2basis set of individual metabolite signals and a residual
signal. State-of-the-art methods generally employ a variant
of least-squares fitting to match a linear combination to
the spectrum. Creating basis sets itself, whether based on
simulation or measurements, is not a trivial task. Further
complicating basis set selection is that basis sets must usu-
ally be specifically created for the pulse sequence used to
acquire the spectra, as the spectra depend on the pulse
sequence. This is problematic as there are many pulse se-
quences and implementations on different systems can vary
considerably [17]. Deriving basis sets from experimental
data is also extremely time-consuming and the resulting
basis sets may suffer from the same problems as the spectra
to be quantified. Alternatively, using simulations for basis
set generation relies on models, the accuracy of which has
been questioned [18]. Quantification, therefore, can be an
extremely time-consuming task, where time must be spent
acquiring or simulating basis sets as well as adjusting fitting
and processing algorithms and parameters. This is where
machine learning has an opportunity to improve quantifica-
tion by providing a complete, unbiased solution in less time.
Machine learning has already proved to be a useful tool in
MR imaging [19], [20], MR spectroscopy [21], [22], [23], [24],
classification of Raman [25] and Faraday spectra [26], and
near-infrared (NIR) spectroscopy calibration [27].
We present MRSNet, a multi-class regression convolu-
tional neural network (CNN) that can be trained quickly on
a relatively small number of samples (5, 000). We review
MRS and associated quantification methods in Section 2.
The data and method for the CNNs are discussed in Sec-
tions 3 and 4 respectively. We focus on frequency domain
analysis by training the CNN on spectra to learn metabo-
lite parameters, returning expected relative concentrations.
Due to the time required to experimentally acquire a large
number of spectra, the network is trained on a range of
simulated data (see Section 5). As the results are heavily
dependent on the accuracy of the basis set and the intra-
basis set scaling, multiple basis sets from different sources
are compared in Section 5.3. Furthermore, a range of net-
work structures and different data representations of the
frequency domain signals (real part, imaginary part and
magnitude) are explored in Section 5.2. The performance of
MRSNet and other state-of-the-art methods is benchmarked
using experimental spectra obtained from test objects (phan-
toms) of known composition (see Section 6). The results
show that on average CNNs are more accurate and precise.
The experimental data used for the evaluation is available
at [28] and the code for the networks and spectral simulation
is available at [29].
2 BACKGROUND
We briefly review the acquisition of MR spectra and state-
of-the-art quantification methods.
2.1 Magnetic Resonance Spectroscopy
MRS utilizes the fact that elementary particles such as
protons, neutrons and electrons have a quantum-mechanical
degree of freedom called spin. As a result, atomic nuclei
with an odd number of protons or neutrons such as hy-
drogen 1H have a net nuclear spin. 1H, the most abundant
element in biological organisms [30], has two spin states.
When an external magnetic field B0 is applied, an energy
gap of hν develops between these states, where h is the
Planck constant and ν is the Larmor frequency, which is
proportional to B0. In a typical clinical MR scanner the
Larmor frequency of 1H is in the radiofrequency (RF)
range, e.g., 127MHz at 3T. As the lower energy state is
energetically preferred, a slight excess of nuclei are found
in this state, leading to the development of a magnetic
moment in the sample. This magnetic moment is almost
undetectable, but when a suitable electromagnetic pulse at
the Larmor frequency is applied, the spins can be rotated
into a plane transverse to the external magnetic field. As the
spins precess in this transverse plane they emit an MR signal
while slowly returning to their equilibrium state, which can
be detected by sensitive RF receive coils.
This time-domain signal is complex, as it has both mag-
nitude and phase, and is Fourier-transformed to obtain the
MR spectrum. The reason for this is that the features in
the frequency-domain representation are directly related to
the structure of the molecule the signal originates from.
Although the Larmor frequency of an isolated proton de-
pends only on the external B0 field, protons in molecules
have slightly shifted resonance frequencies due to chemical
shielding effects, known as chemical shift. Chemical shifts
can be reported in Hz but it is customary to report chem-
ical shifts in ppm (parts-per-million) with respect to the
spectrometer frequency ν0. For a spectrometer calibrated to
127MHz, a chemical shift of 1 ppm corresponds to 127Hz.
Chemical shifts accessible by MR spectroscopy are usually
in the range of 0 ppm to 8 ppm and can be affected by pH
and temperature of the sample. In addition to chemical shift,
MR spectra are also influenced by J -couplings between
nearby spins. This leads to splitting of the energy levels of
the coupled spin system, which manifests itself as splitting
of individual peaks into doublets, triplets, quadruplets, etc.,
depending on the number of spins that are simultane-
ously coupled. In a perfectly homogeneous field and in the
absence of any relaxation the peaks would be δ-function
spikes. In practice, T1 and T2 relaxation of the precessing
spins leads to line broadening and Lorentzian or Gaussian
spectral lineshapes. This intrinsic line broadening is further
increased by local variations in the B0 field, resulting in
a distribution of frequencies over an excited volume. A
homogeneousB0 field correlates with a narrower linewidth,
sharper peaks and, importantly, reduced feature overlap
between metabolite spectra.
In practice, MRS pulse sequences are more complicated
than a single excitation pulse followed by immediate read-
out. Additional pulses must be applied to spatially localize
the signal (Point RESolved Spectroscopy, PRESS) [31] and
suppress unwanted signals such as the background water
signal, e.g., by applying a CHEmical Shift-Selective (CHESS)
pulse to saturate the water signal, followed by gradient
dephasing [32]. Moreover, timing parameters such as TE
(echo time; time between RF pulse and echo readout) and
TR (repetition time; time between corresponding points in a
repeating series of pulses and echoes) are adjusted to reduce
residual magnetization between scans and macromolecular
contributions, among other reasons. All of these choices
affect the spectra obtained.
3Fig. 1: Simulated MEGA-PRESS spectra for mixture of
15mmol/l NAA, 8mmol/l Cr and 3mmol/l GABA (left)
and for GABA only, at much lower signal strength (right).
For edited spectroscopy, such as the MEGA-PRESS
(MEsher-GArwood PRESS) sequence [33], additional editing
pulses are applied between refocusing pulses to selectively
enhance or suppress certain features. The standard MEGA-
PRESS sequence produces two MR spectra, an edit-off and
edit-on spectrum, from which a third difference spectrum is
calculated. Specifically for GABA quantification, the editing
pulses are applied at 1.9 ppm during the edit-on acquisition
and 7.4 ppm during the edit-off acquisition. The aim of these
editing pulses is the elimination of the Cr signal in the
difference spectrum at 3 ppm. As shown in Fig. 1, the small
GABA signal at 3 ppm is completely dominated by the much
larger Cr signal. In the edit-off spectrum, the outer peaks of
the GABA triplet at 3 ppm are inverted compared to the
edit-on spectrum, while the Cr signal is unaffected. In the
difference spectrum, this ensures that the Cr signal at 3 ppm
is eliminated and only the side peaks of the 3 ppm GABA
triplet remain, amplified by a factor of 2, making GABA
detectable. The 2 ppm NAA peak is absent from the edit-
on spectrum as the 1.9 ppm editing pulse also eliminates its
corresponding magnetic moments.
2.2 Quantification of MR Spectra
Quantification of MR spectra aims to infer the relative
contributions (concentrations) of different metabolites, accu-
rately and precisely, even in the presence of environmental
noise and low signal-to-noise ratios. While some metabolites
are quite abundant and relatively easy to quantify, others
of great importance, such as the inhibitory neurotransmit-
ter GABA and the excitatory neurotransmitters Glutamine
(Gln) and Glutamate (Glu) [34], are considerably more chal-
lenging. This is due to low relative concentration in vivo
and overlap of their spectral features with those of more
abundant metabolites [35]. For Glu/Gln the difficulty lies
further in resolving their spectra, which are extremely simi-
lar at the field strength at which most clinical MRI scanners
operate (1.5T or 3T). The primary goal of this paper is
the quantification of these difficult-to-quantify metabolites.
As absolute quantification requires reliable reference spectra
for calibration, which are generally not available for in vivo
spectra, metabolite concentrations are typically reported as
ratios, such as Cr/GABA, NAA/GABA and we also focus
on relative rather than absolute quantification.
Fig. 2: Simplified quantification example for spectrum con-
taining Cr (blue), GABA (orange), Glu (green), Gln (red) and
NAA (purple): simulated combined spectrum with noise
(left), example fit (middle), quantification results (right).
2.2.1 Traditional Approaches
Various quantification methods have been developed, rang-
ing from simple peak integration methods to fitting either
the time or frequency domain signals with a linear com-
bination of basis signals plus a residual in absolute or
relative values as shown in Fig. 2. State-of-the-art meth-
ods typically focus on frequency domain analysis, due to
difficulties interpolating time domain signals with varying
acquisition parameters. The majority implement a variant of
the non-linear least-squares (NLLS) algorithm to fit a set of
parameters to a model. Methods that employ basis sets usu-
ally come bundled with a simulator to generate them. We
briefly describe state-of-the-art software for quantification
and simulation. For an excellent review see [36].
LCModel [37] is widely considered to be the gold stan-
dard of spectral quantification and uses NLLS to decompose
spectra in the frequency domain. Basis sets are provided by
the creator on request or can be obtained from suggested
external sources. LCModel is only able to directly simulate
macro-molecule contributions and not complete basis sets.
In contrast, TARQUIN [38], VeSPA [39] and jMRUI [40]
are able to simulate their own basis sets for quantifica-
tion. TARQUIN and VeSPA both perform NLLS fitting of
frequency domain signals, while jMRUI has a range of
algorithms available, including AMARES and AQSES for
frequency domain analysis and QUEST for the time domain.
Gannet [41] focuses on peak identification and fitting
specifically for edited MRS spectra, such as MEGA-PRESS,
and does not use a basis set or simulator.
Despite the advances made in MR spectra quantification,
it has been shown that there are significant errors in quantifi-
cation between the different methods [36], [42], [43]. Recent
attempts to compare and validate these tools for spectra
obtained from carefully calibrated phantoms have shown
very poor accuracy and large discrepancies between the
concentrations reported by different tools [44], [45]. These
studies highlight the need for more reliable methods for
quantification of MR spectra for MRS to become a reli-
able tool for clinical use, especially for difficult-to-quantify
metabolites such as GABA.
Other methods utilising Bayesian inference have been
developed for the analysis of time-domain signals in high-
field NMR [46]. These leverage prior knowledge via proba-
bility distributions and estimate ‘nuisance parameters’ such
as phase shifts, decay constants and noise parameters, out-
performing Fourier based NMR methods. Due to much
higher spectral resolution and the focus on molecular struc-
4ture elucidation, the issues and applications of high-field
NMR are different and the methods have not been applied
to MRS quantification in vivo.
2.2.2 Machine Learning Approaches
Machine learning for MRS quantification has only recently
begun to be explored. Das et al. [23] used random forests
trained on 1 million simulated spectra and tested on 287
human subjects. More recently Lee et al. [22] trained CNNs
on 40, 000 spectra to quantify a range of simulated and
in vivo data. Both studies are focused on quantification
with the single acquisition PRESS sequence, which generally
precludes identification and quantification of difficult-to-
detect metabolites such as GABA. Furthermore, the perfor-
mance of the machine learning algorithms on in vivo spectra
was assessed by comparing the quantification results with
LCModel. Considering the large discrepancies in metabolite
concentrations reported by different tools when provided
with identical input spectra, and the overall lack of accuracy
of the quantification results obtained with existing tools
when tested against a wide range of spectra from calibrated
phantoms, good agreement with LCModel results does not
provide a strong validation of the method [44], [45].
Here we focus on the quantification of difficult-to-
quantify metabolites in MEGA-PRESS spectra. The net-
works are trained on a comparatively small number of
simulated spectra (5, 000) and the results are validated
independently using calibrated phantom spectra. A range
of network structures, spectra representations, processing
methods and the impact of the basis set choice are explored.
3 DATA
Spectral datasets for quantifying mixtures of NAA, Gln,
Glu, GABA and Cr are used due to their importance for
MRS applications and the difficulty they pose for accurate
quantification. These metabolites are in principle detectable
by MEGA-PRESS. The networks are trained and validated
using simulated data generated by combining simulated
spectral basis sets into spectra based on the concentration
of individual metabolites. Simulated spectral basis sets were
deemed more efficient than deriving basis sets experimen-
tally from calibrated phantoms. Using experimental data to
generate basis sets is also problematic due to the difficulty
of obtaining high-quality spectra [47]. To assess the perfor-
mance of the networks, experimental data from carefully
calibrated phantoms are used as benchmark.
3.1 Training and Validation Dataset Generation
A basis set contains the normalised characteristic signals
in the frequency domain for each metabolite, which are
combined to create mixed spectra.
Basic simulators for basis sets often assume the molecule
is prepared in a well-defined initial state such as the ground
state. They approximate the pulse sequence by a series
of instantaneous unitary operations acting on the state at
certain times, followed by readout of the MR signal, to
simulate the full MRS pulse sequence. More sophisticated
simulators perform time-resolved calculations for finite-
duration pulses and include the effects of relaxation or
field inhomogeneities. However, the choices of pulse shapes
and pulse timings in vendor-specific implementations of
the MEGA-PRESS sequence differ [17] and are often not
known precisely. Therefore, quite often educated guesses
must be made. Similarly, other parameters, such as re-
laxation parameters or field inhomogeneities, are typically
not known precisely. Moreover, even metabolite models,
including chemical shift and J -coupling parameters, still
have uncertainties [18]. A major source of these parameters
for common metabolites in MRS is the landmark paper by
Govindraju et al. [35], but alternative models have been
suggested, e.g., for GABA by Near et al. [48] and Kaiser
et al. [49].
Hence, we use and test different basis sets (see Sec-
tion 6.2) from state-of-the-art simulation and quantification
software: FID-A [50], PyGamma [51] and LCModel [37].
The MEGA-PRESS basis set for LCModel is generated by
the MRS Lab at Purcell Health Sciences [52]. For PyGamma
and FID-A, simulations are performed in house by adapting
the MEGA-PRESS pulse sequence code provided. All sim-
ulations are aimed at the Siemens WIP MEGA-PRESS im-
plementation, which was used to acquire the experimental
datasets (see Section 3.2). These basis sets were also used
in a comparative study of state-of-the-art quantification
methods [44], [45] and the comparison with such methods
in Section 6.1.
For each basis set, the training and validation datasets
are generated by taking linear combinations of the basis
elements with each metabolite having a scaling factor in
[0, 1], corresponding to a relative concentration. The scaling
factors are sampled using a low discrepancy (quasi-Monte
Carlo) Sobol sequence [53], which provides good uniform
coverage of possible states with a low number of data
points. Time-domain noise is added from a normal distri-
bution (µ = 0 and σ randomly chosen in the range [0, 0.25])
to 50% of the dataset to improve simulation accuracy and
network robustness. This noise model was chosen as it
closely resembles what is seen in experimental spectra, by
characterising the noise profile from spectral areas that do
not contain a metabolic signal for 4, 160 phantom spectra.
3.2 Experimental Benchmark Datasets
The performance of the network is evaluated and compared
with other state-of-the-art methods using a spectral bench-
mark dataset created by scanning calibrated phantoms of
the metabolites studied here [28]. The MEGA-PRESS spectra
were acquired on a 3T Siemens Magnetom Skyra system at
Swansea University using the Siemens WIP MEGA-PRESS
implementation with TE = 68ms and TR = 2000ms with
160 averages per spectrum. Four datasets for phantoms of
known composition, E1, E3 & E4a and E4b, were used. E1,
E3 and E4a were acquired with an acquisition bandwidth
of 1250Hz, while E4b was acquired at 2000Hz (for the
same phantoms as E4a). The published experimental dataset
also contains a non-pH calibrated dataset E2, which was
excluded as it was deemed not representative of the in vivo
environment. E4c and E4d, also contained in the dataset, are
repeat runs of E4a and E4b and we obtained similar results
for them, so they are not further discussed here. Phantom
composition is displayed in Table 1 and Fig. 3; for details of
phantom preparation see [44], [45].
5TABLE 1: Benchmark phantom composition: concentrations are in mM = mmol/l.
Series Medium # of Spectra NAA Cr Glu Gln GABA
E1 Water 13 15.0 0/8.0 0.0 0.0 0.0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 4.0, 6.0, 8.0, 10.0, 11.6
E3 Water 15 15.0 8.0 12.0 3.0 0.0, 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 9.0, 10.0, 11.0, 12.0, 13.0, 14.0
E4 Gel 8 15.0 8.0 12.0 3.0 0.0, 1.5, 3.0, 5.0, 7.0, 10.0
Fig. 3: Metabolite concentrations relative to NAA, for
datasets E1, E3 and E4 for NAA (purple: 1), Cr (blue: 0/0.5),
GABA (orange: variable), Gln (red: 0.8), Glu (green: 0.2).
4 METHOD
We present the network structure and training procedure
for MRSNet, our deep MRS quantification network, minimal
data pre-processing and performance evaluation measures.
4.1 Network Structure
MRSNet is a 2D CNN. Input data to the network is a
N × 2048 matrix, where each row contains one component
of a single spectrum. The maximum number of input rows
is N = 9 for the real and imaginary part and magnitude of
up to three spectra (edit-off, edit-on and difference). Spectra
are zero-padded and trimmed to obtain a length of 2048
in the range from 4.5 ppm to 1.5 ppm, i.e. each column is
a single frequency bin 0.0014 ppm wide, providing ample
resolution for small features. The majority of convolutions
are 1×N , spanning across the frequency bins to align with
the separate rows of the input spectra. This network struc-
ture is loosely based on the CNN VGG architecture [54] and
experimentally derived. Multiple layer 1D and 2D networks
and single-layer 3D networks were explored by varying the
arrangement of acquisitions and data type representations.
However, they generally have poor performance compared
to the suggested network structure.
The architecture of the network is designed to train iden-
tification of spectral features in individual rows (component
of a single spectrum) early on, to be combined further down
the network. These reduction layers are implemented in the
middle of the network and repeated to combine the rows
until the output tensor has one row. Using convolutions
spanning multiple rows of the input early on lead to very
poor results, whereas combining the convoluted rows near
the middle of the network provided the best results.
The complete network architecture is shown in Table 2
for the ‘small’ variant without pooling. For every variant
of the network, the layer class reduction1 is repeated until
the output is a tensor with one row. For input spectra with
nine rows, the layer is repeated five times, whereas for an
input of a tensor with one row the layer has a convolutional
kernel sized 3 × 1 and is repeated once. This is where the
TABLE 2: Small network structure without pooling. Elipsis
indicate repeated layers of the same class. Keys: conv: con-
volution; BN: batch normalisation; DO: drop out; FC: fully
connected; ReLU: rectified linear unit.
Layer class Description
input [1− 9]×2048 spectra
conv1 256×1×7 conv, 1×2 stride, ReLU, BN, DO= 0.4
conv2 256×1×5 conv, 1×2 stride, ReLU, DO= 0.4
reduction1 256×[1− 3]×[3] conv, ReLU, DO= 0.25
reduction1 . . .
conv3 256×1×3 conv, padding=same, ReLU, DO= 0.25
reduction2 256×1×3 conv, 1×3 stride, ReLU, DO= 0.25
conv3 . . .
reduction2 . . .
conv4 512×1×3 conv, padding=same, ReLU, DO= 0.25
reduction3 512×1×3 conv, 1x3 stride, ReLU, DO= 0.25
conv4 . . .
reduction3 . . .
dense1 1024 FC Layer
output 5 FC Layer, softmax
TABLE 3: Network layer class substitutions for ‘medium’
and ‘large’ networks, differences are in bold.
Network Layer class Description
Medium conv1 256×1×9 conv, 1×2 stride,
ReLU, BN, DO= 0.4
conv2 256×1×7 conv, 1×2 stride,
ReLU, DO= 0.4
reduction1 256×[1− 3]×5 conv, ReLU, DO= 0.25
Large conv1 256×1×16 conv, 1×2 stride,
ReLU, BN, DO= 0.4
conv2 256×1×8 conv, 1×2 stride,
ReLU, DO= 0.4
reduction1 256×[1− 3]×7 conv, ReLU, DO= 0.25
information contained in the different rows (spectra) of the
input tensor are combined. A variety of substitutions are
made to test different ‘medium’ and ‘large’ networks and
pooling variants as shown in Tables 3 and 4.
The network is trained using the ADAM weight up-
date [55] with an experimentally derived learning rate of
10−4 and suggested beta values of β1 = 0.9 and β2 = 0.999
respectively. Mean squared error (MSE) is used as the loss
function over mean absolute percentage error (MAPE) or
mean absolute error (MAE) due to the higher overall per-
formance seen experimentally. The training was performed
on an NVIDIA Titan X, using Python 2.7.15, Keras 2.2.4 [56]
with Tensorflow 1.9.0 and CUDA 9.0.176.
4.2 Pre-processing
All spectra are B0 corrected w.r.t. the 2 ppm NAA sin-
glet peak due to NAA’s low sensitivity to temperature
of 0.01 ppm/◦C [57]. The experimental spectra are filtered
6TABLE 4: Network substitutions for pooling variants where
strided convoloutions are replaced by a MaxPool layer
following a convoloution layer.
Network Layer class Description
All (pooling) reduction2 256×1×3 conv, ReLU, DO= 0.25
1×3 MaxPool
reduction3 512×1×3 conv, ReLU, DO= 0.25
1×3 MaxPool
using a first-order Butterworth filter to reduce noise and
with no phase correction done for simplicity, as it can
often require human interaction [58]. Experimental and
simulated spectra are mean-centred and normalised so that
the largest peak has amplitude ±1 across acquisitions with
x′ = x/max(|x|). Different acquisition bandwidths are
dealt with by zero-filling the time domain signal to achieve a
spectral resolution of 2048 points in the selected ppm range.
4.3 Performance Evaluation
The error  is calculated as the mean of the absolute dif-
ferences of the actual ai,j and the predicted pi,j relative
concentration for every label (metabolite) j = 1, . . . , L, for
every prediction (spectrum) i = 1, . . . , N :
 =
1
NL
N∑
i=1
L∑
j=1
|ai,j − pi,j |. (1)
The standard deviation σ is calculated in the usual way,
σ2 =
∑N
i=1
∑L
j=1(pi,j − )2/(NL). This provides a good
indication of overall network performance but is insensitive
to low concentration metabolites. To counter this, an in-
depth regression and MAPE analysis is performed for the
best network on a per-metabolite basis in Section 6.1.
5 EXPERIMENTS
We investigate a range of network structures, spectra, repre-
sentations and basis sets to find a favourable combination.
Network structure and batch sizes are investigated first, fol-
lowed by the effect of different representations of the spectra
and the choice of basis set. The LCModel basis set is used for
the first two experiments as the analysis program has been
shown to perform well by the comparative study in [44],
[45] and it performs best compared to other state-of-the-
art quantification methods (see Table 9), suggesting a good
fit with experimental data. Training and validation are per-
formed using simulated spectra as described in Section 3.1.
Initial experiments in Sections 5.1 and 5.2 are trained for 100
epochs, with 4, 000 training, 1, 000 validation samples. For
the final experiment in Section 5.3, more compute time is
dedicated to refining the networks over 200 epochs with
5, 000 training samples. A light early stopping criteria is
utilised throughout to prevent overfitting, with a minimum
loss decrease of 10−12, a patience (number of epochs with-
out improvement) of 15 and ‘restore best weights’ enabled.
Network performance is benchmarked using experimental
datasets from samples with known composition rather than
performance on validation as described in Section 3.2.
5.1 Network Structure Investigation
An initial investigation is performed to explore the effect
of minibatch sizes, convolutional kernel widths and pooling
vs. stridden convolutions on performance with the bench-
mark datasets. Three variants of the network are tested
(small, medium and large) over a range of minibatch sizes
(64, 32, 16) for two major variants of each network, either
using stridden convolutions or max-pooling. These two
variants are explored as convolutions with strides have been
shown to be advantageous over max-pooling methods [59].
Networks are trained using all three spectra (edit-off, edit-
on and difference) and all three data representations (real,
imaginary and magnitude/absolute value) stacked to form
a 9 × 2048 input tensor for each sample. The results in
Tables 5 and 6 show the general trend that using convo-
lutions with strides obtains a substantially higher perfor-
mance over max-pooling. Networks with smaller convo-
lutional kernels are substantially quicker than their larger
counterparts as they are less computationally expensive to
calculate. The ‘small’ network, using stridden convolutions
and a minibatch size of 64 achieves a good balance between
performance and training time on the benchmark datasets,
making it the chosen network architecture for the following
experiments.
5.2 Effect of Different Representations of Spectra
Using MEGA-PRESS data provides a unique opportunity
to explore how training networks on different combinations
of acquired spectra for one scan (edit-off, edit-on and dif-
ference) affects performance. Additionally, three data types
have been chosen to represent the spectrum by taking the
real, imaginary or magnitude component of the frequency
domain signal. These components are explored by using the
same generated dataset for training and validation but con-
sidering different combinations of spectra and data types.
Results in Table 7 show a clear performance advantage
of utilising the magnitude representation for all acquisition
types. This is expected, as there is a level of phase uncer-
tainty from the experimental signal leading to a potential
disagreement with the real and phase spectra from the
benchmark set when compared to the basis set. However,
using the magnitude spectra does increase the linewidth
when compared to only the real spectrum; which is typically
preferred for quantification for this reason. Despite this, the
networks prefer the more predictable magnitude spectra, at
the cost of dealing with the increased linewidth.
The best combination of acquisitions is the edit-off and
difference, as these provide the maximal amount of informa-
tion with no repetition of data. The reduced performance
for the difference only acquisition can be attributed to the
Cr spectra, wherein the LCModel basis set that was used to
train the network assumes perfect editing, where the normal
and inverted spectrum in the edit-on and edit-off acquisition
match amplitude. As such, there is no residual Cr signal in
the difference spectrum (which is not always the case in
practice), as it has been edited out leading to difficulties in
quantification. Networks perform worse when redundant
data is supplied, for example, in the case of using the edit-
off, on and difference magnitude spectra. This could be
because the network is provided with too many degrees of
7TABLE 5: Performance of network trained with LCModel basis set, three acquisitions, three data types using convolutions
with strides.
Batch Network s/Epoch Train Validation E1 E3 E4a E4b
16 Small 51 0.00933 σ 0.008 0.01113 σ 0.011 0.12954 σ 0.099 0.08898 σ 0.075 0.07845 σ 0.056 0.10344 σ 0.080
16 Medium 90 0.00858 σ 0.008 0.01090 σ 0.011 0.14440 σ 0.126 0.08013 σ 0.064 0.08157 σ 0.055 0.11970 σ 0.074
16 Large 112 0.00769 σ 0.007 0.00968 σ 0.011 0.12680 σ 0.106 0.07382 σ 0.051 0.08439 σ 0.057 0.12502 σ 0.068
32 Small 50 0.01096 σ 0.010 0.01293 σ 0.013 0.11980 σ 0.099 0.08003 σ 0.063 0.06619 σ 0.053 0.13130 σ 0.093
32 Medium 84 0.00948 σ 0.009 0.01194 σ 0.012 0.14928 σ 0.127 0.08752 σ 0.070 0.09360 σ 0.059 0.12649 σ 0.076
32 Large 100 0.01169 σ 0.010 0.01409 σ 0.013 0.17127 σ 0.134 0.06996 σ 0.043 0.06271 σ 0.046 0.10637 σ 0.081
64 Small 48 0.01150 σ 0.010 0.01274 σ 0.012 0.11599 σ 0.092 0.07378 σ 0.060 0.07168 σ 0.048 0.12210 σ 0.090
64 Medium 81 0.00961 σ 0.008 0.01135 σ 0.011 0.12914 σ 0.111 0.09217 σ 0.067 0.11139 σ 0.049 0.13296 σ 0.074
64 Large 96 0.01348 σ 0.011 0.01567 σ 0.014 0.11031 σ 0.097 0.11308 σ 0.080 0.10906 σ 0.093 0.08609 σ 0.085
TABLE 6: Performance of network trained with LCModel basis set, three acquisitions, three data types using max pooling.
Batch Network s/Epoch Train Validation E1 E3 E4a E4b
16 Small 52 0.02319 σ 0.020 0.02537 σ 0.022 0.23780 σ 0.183 0.12593 σ 0.086 0.14338 σ 0.100 0.16654 σ 0.093
16 Medium 91 0.02155 σ 0.018 0.02419 σ 0.022 0.25608 σ 0.203 0.12456 σ 0.095 0.14460 σ 0.097 0.18350 σ 0.108
16 Large 114 0.02955 σ 0.024 0.03267 σ 0.027 0.23548 σ 0.203 0.10779 σ 0.085 0.11319 σ 0.088 0.15390 σ 0.100
32 Small 49 0.02550 σ 0.021 0.02848 σ 0.024 0.24714 σ 0.194 0.14428 σ 0.107 0.15845 σ 0.115 0.16844 σ 0.097
32 Medium 85 0.02825 σ 0.022 0.03044 σ 0.025 0.26010 σ 0.203 0.11713 σ 0.084 0.11767 σ 0.089 0.16157 σ 0.086
32 Large 101 0.02463 σ 0.019 0.02652 σ 0.022 0.23353 σ 0.153 0.11028 σ 0.061 0.10509 σ 0.068 0.11382 σ 0.074
64 Small 48 0.02502 σ 0.021 0.02701 σ 0.024 0.25574 σ 0.175 0.13671 σ 0.103 0.14247 σ 0.109 0.14566 σ 0.089
64 Medium 82 0.03168 σ 0.025 0.03358 σ 0.027 0.24458 σ 0.197 0.12839 σ 0.095 0.15139 σ 0.105 0.14814 σ 0.097
64 Large 97 0.04081 σ 0.028 0.04236 σ 0.030 0.24200 σ 0.196 0.11145 σ 0.087 0.10594 σ 0.082 0.15611 σ 0.097
TABLE 7: Network performance for different combinations of acquired spectra (edit-off, edit-on, difference) and data types
(real: R, imaginary: I, magnitude: M) using the ‘small’ network with strided convoloutions and the LCModel basis for
training and validation dataset generation.
Acquisitions Data type(s) Train Validation E1 E3 E4a E4b
Off R 0.01386 σ 0.011 0.01521 σ 0.014 0.13292 σ 0.089 0.10046 σ 0.080 0.08394 σ 0.065 0.10424 σ 0.084
Off I 0.01265 σ 0.012 0.01494 σ 0.014 0.13159 σ 0.092 0.07989 σ 0.054 0.09348 σ 0.067 0.11512 σ 0.070
Off M 0.01565 σ 0.016 0.01949 σ 0.024 0.06863 σ 0.054 0.07800 σ 0.063 0.06419 σ 0.050 0.07662 σ 0.054
Off R I 0.01203 σ 0.011 0.01400 σ 0.013 0.09873 σ 0.064 0.10943 σ 0.075 0.09235 σ 0.067 0.08462 σ 0.072
Off R I M 0.01105 σ 0.010 0.01366 σ 0.013 0.10024 σ 0.062 0.09750 σ 0.050 0.08600 σ 0.059 0.09015 σ 0.078
On R 0.01453 σ 0.013 0.01695 σ 0.017 0.22904 σ 0.192 0.13183 σ 0.124 0.11652 σ 0.100 0.17211 σ 0.077
On I 0.01256 σ 0.012 0.01570 σ 0.017 0.22129 σ 0.191 0.13696 σ 0.133 0.12930 σ 0.119 0.19410 σ 0.112
On M 0.01944 σ 0.019 0.02567 σ 0.030 0.21743 σ 0.200 0.15283 σ 0.100 0.15292 σ 0.098 0.16059 σ 0.095
On R I 0.01369 σ 0.012 0.01648 σ 0.018 0.23515 σ 0.182 0.13795 σ 0.130 0.13242 σ 0.114 0.19135 σ 0.101
On R I M 0.01468 σ 0.014 0.01851 σ 0.019 0.23231 σ 0.194 0.17241 σ 0.135 0.18429 σ 0.101 0.19757 σ 0.095
Diff R 0.04300 σ 0.041 0.04888 σ 0.047 0.08484 σ 0.073 0.09208 σ 0.059 0.09231 σ 0.071 0.10738 σ 0.081
Diff I 0.03993 σ 0.040 0.04649 σ 0.046 0.06341 σ 0.066 0.11511 σ 0.066 0.11253 σ 0.070 0.10329 σ 0.092
Diff M 0.04142 σ 0.041 0.05125 σ 0.050 0.04967 σ 0.063 0.08806 σ 0.069 0.08591 σ 0.066 0.10017 σ 0.074
Diff R I 0.03963 σ 0.040 0.04671 σ 0.047 0.07428 σ 0.066 0.07755 σ 0.047 0.07148 σ 0.052 0.08196 σ 0.063
Diff R I M 0.03918 σ 0.040 0.04647 σ 0.047 0.07753 σ 0.079 0.06767 σ 0.046 0.08112 σ 0.057 0.09246 σ 0.061
Off On R 0.01396 σ 0.011 0.01626 σ 0.014 0.20498 σ 0.159 0.18993 σ 0.146 0.16938 σ 0.135 0.14621 σ 0.082
Off On I 0.01425 σ 0.012 0.01640 σ 0.014 0.23126 σ 0.170 0.16219 σ 0.128 0.15234 σ 0.120 0.19090 σ 0.095
Off On M 0.01415 σ 0.012 0.01642 σ 0.016 0.14484 σ 0.118 0.11244 σ 0.086 0.12549 σ 0.078 0.13234 σ 0.070
Off On R I 0.01434 σ 0.013 0.01636 σ 0.015 0.18232 σ 0.135 0.16390 σ 0.093 0.15403 σ 0.095 0.15630 σ 0.072
Off On R I M 0.01618 σ 0.013 0.01801 σ 0.016 0.15784 σ 0.132 0.17001 σ 0.130 0.12872 σ 0.105 0.12797 σ 0.080
Off Diff R 0.01361 σ 0.011 0.01440 σ 0.013 0.06866 σ 0.053 0.08917 σ 0.051 0.07371 σ 0.051 0.09721 σ 0.076
Off Diff I 0.01203 σ 0.011 0.01358 σ 0.013 0.07983 σ 0.053 0.04921 σ 0.028 0.05918 σ 0.042 0.10686 σ 0.081
Off Diff M 0.01549 σ 0.013 0.01759 σ 0.017 0.05956 σ 0.042 0.04519 σ 0.031 0.04288 σ 0.034 0.06034 σ 0.054
Off Diff R I 0.01292 σ 0.011 0.01461 σ 0.013 0.11167 σ 0.090 0.05455 σ 0.043 0.04936 σ 0.037 0.10697 σ 0.082
Off Diff R I M 0.01344 σ 0.012 0.01509 σ 0.015 0.07955 σ 0.057 0.11050 σ 0.074 0.09290 σ 0.059 0.10666 σ 0.085
On Diff R 0.01704 σ 0.014 0.01819 σ 0.016 0.20824 σ 0.177 0.14069 σ 0.106 0.14328 σ 0.103 0.17063 σ 0.080
On Diff I 0.01439 σ 0.012 0.01552 σ 0.014 0.19468 σ 0.161 0.13248 σ 0.087 0.13502 σ 0.084 0.17786 σ 0.098
On Diff M 0.01888 σ 0.018 0.02156 σ 0.022 0.15265 σ 0.131 0.10383 σ 0.078 0.12364 σ 0.076 0.12842 σ 0.056
On Diff R I 0.01673 σ 0.014 0.01840 σ 0.016 0.22594 σ 0.191 0.15966 σ 0.118 0.15320 σ 0.106 0.19460 σ 0.086
On Diff R I M 0.01957 σ 0.019 0.02295 σ 0.022 0.23033 σ 0.184 0.16489 σ 0.111 0.17125 σ 0.101 0.17671 σ 0.091
Off On Diff R 0.01326 σ 0.011 0.01486 σ 0.013 0.13909 σ 0.086 0.09442 σ 0.067 0.08806 σ 0.058 0.10422 σ 0.083
Off On Diff I 0.01251 σ 0.010 0.01393 σ 0.012 0.16848 σ 0.112 0.08873 σ 0.081 0.09467 σ 0.081 0.14555 σ 0.085
Off On Diff M 0.01336 σ 0.011 0.01517 σ 0.014 0.07679 σ 0.055 0.06491 σ 0.053 0.06009 σ 0.040 0.06971 σ 0.046
Off On Diff R I 0.01624 σ 0.013 0.01710 σ 0.015 0.15457 σ 0.107 0.13011 σ 0.067 0.14073 σ 0.074 0.15130 σ 0.086
Off On Diff R I M 0.01418 σ 0.012 0.01612 σ 0.014 0.14309 σ 0.104 0.08350 σ 0.073 0.09529 σ 0.070 0.11978 σ 0.081
8freedom, increasing the training difficulty. For the following
experiments, we choose networks that use the magnitude
edit-off and difference spectra as inputs.
5.3 Choice of Basis Set
We compare the performance of three basis sets from
LCModel, PyGamma and FID-A as described in Section 3.1
as differences in the basis sets may have a significant im-
pact on quantification performance [44], [45]. Networks are
trained and tested using the magnitude of the edit-off and
difference spectrum with an increased number of training
samples 5, 000, 1, 000 validation and test spectra, and with
an increased number of 200 epochs for training.
Datasets were generated using the same metabolite con-
centration and noise values across the three basis sets to
create a like-for-like comparison. Results in Table 8 suggest
that for overall quantification, the single linewidth (1Hz)
FID-A basis performs the best for E1, E4a and E4b, while the
LCModel basis outperforms the others for the E3 dataset.
The PyGamma basis performs substantially worse overall.
This suggests that overall the FID-A basis set is the best
choice for training the network for general quantification.
We also investigate the effect of training the networks
on basis sets generated with multiple linewidths (MLW).
In practice, the linewidth of the experimental spectra is
variable, depending on a multitude of environmental factors
as described in Section 2.1. Spectra are simulated using basis
sets with linewidths of 0.75Hz, 1Hz and 1.25Hz for the
PyGamma and FID-A basis sets. For LCModel this was not
possible as there is only one fixed linewidth basis set and
we do not have access to the underlying generator. The
network is trained using the same values for metabolite
concentrations and noise as the single linewidth experi-
ment. The generated spectra are split evenly between the
defined linewidths. Table 8 shows that the overall accuracy
of the networks trained with PyGamma improves but is
marginally worse for FID-A. The use of simulators over
fixed basis sets could be advantageous here as training
a network on a range of linewidths should allow it to
generalise to broader linewidths, typically seen in practice.
However, in this instance, it appears that the linewidth of
1Hz for FID-A closely matches the experimental spectra and
using multiple linewidths has provided no improvement.
6 EVALUATION
Overall the best performing network is the ‘small’ variant
with stridden convolutions, using the magnitude of the edit-
off and difference spectra. We evaluate its overall perfor-
mance and compare it with state-of-the-art methods.
6.1 Comparison with State-of-the-art Methods
Unlike previous sections where performance was measured
against all five metabolites, the performance in this section
is evaluated on reduced sets of metabolites (see Table 9).
The sets are based on which metabolites are present in the
phantom and an intersection of metabolites the selected pro-
grams can report. Cr is omitted from the analysis as it is not
reported by LCModel for MEGA-PRESS difference analysis.
Glu and Gln values are combined and reported as GLX as
they are generally considered unresolvable at 3T due to
their similar chemical structure and resulting spectrum. For
the reduced metabolite sets, reported concentration values
are re-scaled to c′r = cr/
∑
r∈R cr where R is the index set
of the reduced metabolite set.
Quantification software settings, results and procedures
are available in [44], [45]. The error measures have been
changed to focus on individual metabolite error for this
article rather than the NAA/GABA ratio.
The results in Table 9 show that overall MRSNet is more
accurate and precise than other methods for quantification
using MEGA-PRESS. In contrast to the results in Table 8,
training the network with the LCModel basis set provides
the best performance in this instance. This performance
increase is due to the reduced set of metabolites for anal-
ysis. However, when evaluating MRSNet performance in
the general case across all metabolites the FID-A basis set
outperforms the LCModel basis on average.
To further understand and analyse the performance of
the network, regression analysis is performed for GABA
and NAA across all benchmark datasets for LCModel and
MRSNet trained with the LCModel basis due the perfor-
mance advantage shown in Table 9. Results in Fig. 4 show
that the performance of MRSNet is comparable to LCModel,
except for E4b, where both struggle. The E4b dataset is con-
siderably noisier than the others and the performance may
be due to LCModel’s pre-processing steps. Analysis of all
series shows that only E4b suffers from inversion of the edit-
on or off spectrum, resulting in a poor difference spectrum,
caused by the MRI scanner software (also see [45]).
To further investigate, individual metabolite error and
MAPE values are calculated in Table 10. A similar trend con-
tinues, where MRSNet outperforms LCModel on average,
except for GABA quantification which bounces between
LCModel and MRSNet trained with the FID-A ‘MLW’ basis,
suggesting that the GABA model from FID-A may be a
better fit to experimental data.
The large error seen in Table 9 can be attributed to the
performance of NAA quantification, as it has the highest
concentration in all benchmark phantoms. Any improve-
ment seen in NAA quantification has the largest impact on
the error in Eq. (1) and is reflected in the overall performance
in Table 9. While NAA is not typically the target of edited
MRS, it can be utilised as an internal reference compound.
So any improvement in the accuracy of NAA would indi-
rectly improve quantification for all other metabolites.
6.2 Basis Comparison
The variety of performance shown in the basis comparison
experiment and subsequent MAPE analysis (see Tables 8
and 10) can be explained by the variance of spectra gener-
ated from three data sources. As mentioned in Section 3.1,
dataset and simulator creators have a large range of options
available to them for simulation parameters, along with a
range of metabolite models, resulting in a large range of
possible spectra.
Fig. 5 compares the difference spectra from PyGamma,
FID-A and LCModel with an additional in-house experi-
mentally acquired pure GABA phantom spectrum using
MEGA-PRESS. From visual inspection, it is clear to see that
9TABLE 8: A comparison of basis set influence on MRSNet performance, using the ‘small’ network with stridden
convoloutions. Networks are trained using the magnitude of the edit-off and difference acqusition. MLW denotes that
the dataset is comprised of multiple linewidth spectra.
Basis Train Validation E1 E3 E4a E4b
LCModel 0.01206 σ 0.009 0.01547 σ 0.017 0.07936 σ 0.061 0.04553 σ 0.035 0.04991 σ 0.038 0.06702 σ 0.046
FID-A 0.01120 σ 0.009 0.01374 σ 0.013 0.04744 σ 0.035 0.05323 σ 0.036 0.04670 σ 0.033 0.05960 σ 0.049
FID-A MLW 0.00995 σ 0.008 0.01308 σ 0.013 0.04773 σ 0.035 0.05963 σ 0.041 0.05407 σ 0.040 0.06302 σ 0.051
PyGamma 0.01337 σ 0.012 0.01688 σ 0.017 0.09081 σ 0.071 0.09496 σ 0.057 0.09396 σ 0.064 0.10269 σ 0.066
PyGamma MLW 0.01133 σ 0.009 0.03436 σ 0.037 0.08465 σ 0.061 0.07521 σ 0.058 0.06994 σ 0.062 0.08147 σ 0.064
TABLE 9: Performance of state-of-the-art quantification programs compared to the best network (‘small’ with stridden
convolutions). Multiple networks have been trained with different basis sets, including multiple linewidth bases (MLW),
with results evaluated on reduced metabolite sets to enable a like-for-like comparison with the external analysis programs.
E1 E3 E4a E4b
Metabolite set [NAA, GABA] [NAA, GABA, GLX] [NAA, GABA, GLX] [NAA, GABA, GLX]
Analysis program
VeSPA 0.1192 σ 0.096 0.1199 σ 0.081 0.1552 σ 0.105 0.2016 σ 0.122
TARQUIN 0.1125 σ 0.093 0.0708 σ 0.049 0.0705 σ 0.070 0.1341 σ 0.090
LCModel 0.0462 σ 0.030 0.0956 σ 0.041 0.0919 σ 0.054 0.1266 σ 0.095
jMRUI (AQUES)† 0.2081 σ 0.092 0.1432 σ 0.088 0.1865 σ 0.117 -
jMRUI (QUEST) † 0.2044 σ 0.098 0.1402 σ 0.080 0.1958 σ 0.144 -
Gannet 0.1405 σ 0.103 0.3092 σ 0.158 0.3012 σ 0.179 0.5334 σ 0.603
MRSNet trained with
LCModel 0.0318 σ 0.014 0.0321 σ 0.021 0.0402 σ 0.022 0.0720 σ 0.050
FID-A 0.0746 σ 0.044 0.0617 σ 0.034 0.0402 σ 0.033 0.0735 σ 0.060
FID-A MLW 0.0636 σ 0.032 0.0714 σ 0.044 0.0722 σ 0.041 0.0864 σ 0.054
PyGamma 0.0408 σ 0.021 0.0842 σ 0.057 0.0674 σ 0.041 0.0994 σ 0.063
PyGamma MLW 0.0501 σ 0.022 0.0708 σ 0.044 0.0679 σ 0.044 0.0704 σ 0.055
† Quantification was not performed for the E4b dataset.
LCModel, VeSPA and jMRUI report individual Glu and Gln values which have been combined into GLX. Gannet and TARQUIN
report the combined GLX.
Fig. 4: Regression analysis for the best network architecture (‘small’, stridden convoloutions) trained using the LCModel
basis set (blue, ?) compared with LCModel analysis (orange, ×) for GABA (top row) and NAA (bottom row) across all
benchmark datasets (from left to right, E1, E3, E4a, E4b). R2, Slope (sl), intercept (int), p-value (p), and standard error (se)
values are displayed on each graph in the legend. The ideal quantification method would have a slope of 1 and an intercept
at 0, as represented by the faint grey diagonal line.
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TABLE 10: Individual metabolite MAPE for state-of-the-art quantification programs compared to the best network (‘small’
with stridden convolutions). Multiple networks have been trained with different basis sets, including multiple linewidth
bases (MLW). See Table 9 for omission explanations.
E1 E3 E4a E4b
NAA GABA NAA GABA GLX NAA GABA GLX NAA GABA GLX
Program
TARQUIN 16.26% 69.98% 10.64% 47.63% 18.62% 13.04% 158.19% 28.55% 7.93% 100.93% 27.17%
VeSPA 16.96% 66.64% 43.52% 49.96% 23.00% 48.17% 82.69% 43.79% 54.42% 217.30% 55.48%
LCModel 6.53% 24.62% 35.35% 34.68% 21.82% 31.08% 35.20% 24.61% 42.49% 39.08% 33.62%
jMRUI (AQSES) 24.12% 221.87% 18.65% 133.39% 40.34% 18.37% 312.78% 57.14% -
jMRUI (QUEST) 23.47% 215.59% 12.90% 134.90% 47.68% 21.50% 332.47% 57.12% -
Gannet 20.13% 76.41% 114.12% 57.56% 87.59% 102.48% 44.97% 90.06% 99.92% 139.99% 135.18%
MRSNet with
LCModel 3.89% 25.29% 4.59% 27.93% 10.53% 5.15% 52.59% 13.30% 11.22% 104.94% 17.08%
FID-A 10.37% 42.56% 22.63% 18.20% 15.02% 11.60% 30.97% 10.42% 13.00% 85.83% 16.41%
FID-A MLW 8.71% 36.90% 25.87% 11.45% 20.08% 22.85% 29.17% 19.70% 20.05% 84.95% 21.46%
PyGamma 5.18% 30.33% 14.13% 57.37% 29.63% 5.71% 123.52% 19.85% 13.35% 160.74% 22.14%
PyGamma MLW 6.14% 44.89% 13.15% 53.56% 23.65% 8.61% 83.27% 22.63% 7.00% 87.71% 22.52%
Fig. 5: Example of spectra differences for the magni-
tude MEGA-PRESS difference GABA spectra from multiple
sources, from top to bottom: PyGamma, FID-A, LCModel,
experimental spectrum.
none of the simulated data sources aligns perfectly with the
experimental spectrum. This may be due to a multitude of
reasons, including each simulator using a different GABA
model: PyGamma uses Govindaraju et al. [35], FID-A uses
Near et al. [48] and LCModel uses Kaiser et al. [49]. All
simulators use Govindaraju et al.’s [35] values for the other
metabolite models. A different GABA model is often chosen
due to the well-known issue that the values in [35] are
rough approximations of the true values [18]. In addition to
simulation parameters, there is a multitude of experimental
factors that can alter the resulting spectrum, further com-
plicating the issue of matching simulation to experimental
results. In an ideal scenario, networks should be trained on
a large range of experimental data to cover the potential
variation of spectra. However, in practice, this is a non-
trivial task, with phantom creation being difficult and time-
consuming in addition to needing a large amount of data to
cover the potential experimental variations of the spectra.
6.3 Benefits and Limitations
MRSNet is quick to train on GPUs (18 minutes on an
NVIDIA Titan X GPU), with a relatively low number of
samples (5, 000). Once trained, it requires no special hard-
ware and it takes on average 24±2ms to process a single
spectrum with the network, using a dual-core 2.7GHz i7-
7500u CPU, with the network occupying 95MB disk space.
Furthermore, it requires no interaction from a user with
specialist knowledge for potentially complicated processing
steps, such as phase-correction.
The data type and channel experiments in Section 5.2
is not generally applicable to all basis sets in Table 8, as
this study was only performed using the LCModel basis set.
As shown, other basis sets have different spectra and may
have a more accurate representation of real or phase data,
but it is expected that the magnitude spectra will remain
the best performing due to the issue of uncertainty in phase
reconstruction from the scanner.
Networks in this paper are only trained and tested with
one timing variant of a single pulse sequence (MEGA-
PRESS at 3T with TR = 68ms, TE = 2000ms) with a
benchmark dataset collected from one scanner, and for a
single frequency window (4.5 ppm to 1.5 ppm). This net-
work should generalise to different MEGA-PRESS spectra,
but it is unlikely that it will work as accurately with different
strength B0 fields, scanner manufacturers, pulse sequences
or pulse sequence timings without further training.
Finally, in vivo data has not been used to evaluate this
method due to the lack of ground truth data, which would,
of course, be very difficult to obtain. Additionally, we have
chosen to explore a limited number of metabolic signals,
while there is a much larger range of spectra and macro-
molecule signals that are obtainable with MRS in vivo.
7 CONCLUSIONS AND FUTURE WORK
We have demonstrated that the overall accuracy and preci-
sion of metabolite quantification in MRS is improved by a
convolutional neural network by comparing its performance
to current state-of-the-art methods. We have found that a 2D
CNN, using stridden convolutions, and utilising ‘small’ 1×N
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convoloutions along the frequency axis of the input spectra
is the best performing network architecture.
Additionally, we have explored a range of data sources
for training and representations for the input spectra. This
has shown that the edit-off and difference absolute spectra
provide the best results for the benchmark datasets. Fur-
thermore, in the general case, training the network should
be done with the FID-A basis, however, when looking at
a reduced set of metabolites that excludes Creatine, the
LCModel basis outperforms the alternatives. This highlights
the non-trivial task of basis set selection and the need for
more accurate characterisation.
There is a range of directions for future work, as this
study focuses on the frequency domain for a single pulse
sequence at one TE , TR timing for five metabolites. Different
representations of the input data could be investigated,
such as using the complex time-domain signal, multiple
TE acquisitions, multiple short-time Fourier transforms or
reduced frequency domain data such as peak locations,
amplitudes and phases. Networks could be trained and
tested for a larger number of metabolites and a range of
pulse sequences and timings to see how well they can learn
to generalise. Importantly, such work must continue to be
linked to experimental work with calibrated phantoms to
try to ensure accuracy and reliability in vivo.
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